Preliminary single-center experience of Helicobacter pylori eradication among the liver transplant recipients.

The prevalence of H. pylori infection was 19.6% among the LT recipients, which increased with the postoperative time. With BQT, H. pylori eradication was safe and effective in LT recipients.